Karen Drexler
Director
diaDexus, Inc. Committee Membership: Chair, Compensation Committee
Karen Drexler has spent the last 15 years co-founding and building medical device companies, mainly in the diagnostics space. She joined the diaDexus Board of Directors in November, 2010 and chairs the Compensation Committee.
Karen was President and CEO of Amira Medical, a glucose monitoring company that was sold to Roche in 2001. She is currently active with CellScape Corporation, Mountain View, CA (Chairperson, co-founder – prenatal diagnostics), Medivoce, Menlo Park, CA (co-founder, President and Board member – patient instructional materials), Orsense, Rehovoth, Israel, (Director – noninvasive patient monitoring) and the Keller Center for Innovation in Engineering Education, Princeton University. Karen also acts as a senior strategic advisor for several other early stage companies.
The holder of 11 issued and two pending patents, Karen received her MBA from the Graduate School of Business, Stanford University and her BSE in Chemical Engineering from Princeton University.